Search Results 161-170 of 10615 for Autoimmune haemolytic anaemia

  1. Hydroxychloroquine (oral route) - Side effects & dosage - Mayo Clinic

    Glucose-6-phosphate dehydrogenase (G6PD) deficiency—May cause hemolytic anemia in patients with this condition. Heart disease (eg, heart attack, heart ...

  2. Autoimmune hepatitis - Doctors and departments - Mayo Clinic

    This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

  3. ANA test - Mayo Clinic

    This is a test used to help diagnose an autoimmune disease such as lupus or rheumatoid arthritis.

  4. Autoimmune encephalitis - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Novel biomarkers, diagnostic clues and new treatments for autoimmune encephalitis are being studied in the Center for Multiple Sclerosis and Autoimmune ...

  5. Publications - Jithma P. Abeykoon, M.D. - Mayo Clinic

    Babesiosis-induced warm autoimmune hemolytic anemia, from infection to hemolysis: a case report. J Med Case Rep. 2025 Aug 11; 19 (1):400. View PubMed ...

  6. Stroke - Doctors and departments - Mayo Clinic

    , Thoracic outlet syndrome, Autoimmune hemolytic anemia, Hemophilia, Antiphospholipid syndrome, Immune thrombocytopenia, von Willebrand disease ...

  7. Immune Deficiencies Clinical Trials - Mayo Clinic Research

    ... autoimmune disease and neoplasias. The samples collected in this study will provide a valuable and unique sample database that will permit formulation of ...

  8. Stroke - Doctors and departments - Mayo Clinic

    , Thoracic outlet syndrome, Autoimmune hemolytic anemia, Hemophilia, Antiphospholipid syndrome, Immune thrombocytopenia, von Willebrand disease ...

  9. Autoimmune hepatitis - Doctors and departments - Mayo Clinic

    This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

  10. A Phase 2 Master Protocol Assessing Inebilizumab And Blinatumomab In Autoimmune Diseases - Mayo Clinic

    A Phase 2 Master Protocol Assessing Inebilizumab And Blinatumomab In Autoimmune Diseases. Print details. Share; Facebook · Twitter. Overview; Participation ...